JPMorgan raises AbbVie target price to $300
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui October 10｜JPMorgan has raised the target price of AbbVie from $285 to $300 and maintained an "Overweight" rating.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Dogecoin ETF to Shut as Bitwise CEO Flags Weak Demand
CoinCryptoNewz•2026/10/10 10:57
TD Cowen lowers UnitedHealth target price to $402
格隆汇•2026/10/10 09:31
Specter questions the issuance and refund arrangements of Serpin token
AiCoin•2026/10/10 09:29
BMO raises target price for cybersecurity stocks
格隆汇•2026/10/10 09:19
